|
![]() |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Tempo Scan Pacific Tbk, PT Headquarters 5/F Bina Mulia II Building Jln H.R Rasuna Said Kav 11; Jakarta; Jakarta; 12950 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : ID1000104508 Financial Auditors: Tanubrata Sutanto Fahmi & Rekan (2011) Incorporation Date: May 20, 1970 Total Employees: 5,000 Tel: (62 21) 5201858 |
|
Company Description |
| PT. Tempo Scan Pacific Tbk (TSPC) is engaged principally in the pharmaceutical business. The scope of activities of the subsidiaries comprises of manufacturing and marketing of pharmaceutical products, health care, cosmetics and distribution services. To support its operational activities, TSPC has three operating divisions, which are the pharmaceutical division, the personal care and cosmetic division (consumer products division) and the distribution division. The pharmaceutical division produces | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues increased with 14.61%, from IDR 4,244,800,473 thousands to IDR 4,865,158,764 thousands. Operating result increased from IDR 575,248,704 thousands to IDR 625,187,264 thousands which means 8.68% change. The results of the period increased 9.57% reaching IDR 549,313,152 thousands at the end of the period against IDR 501,348,736 thousands last year. Return on equity (Net income/Total equity) went from 16.82% to 16.82%, the Return On Asset (Net income / Total Asset) went from 12.20% to 12.17% and the Net Profit Margin (Net Income/Net Sales) went from 11.81% to 11.29% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 39.12% compared to 39.64% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.23 to 3.20 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |

|
|
2012 Y (cons) |
2012 Q3C (cons) |
|
![]() | ||
| Audited | Non-Audited | |
![]() | ||
| WVB Company Financials | WVB Company Financials | |
![]() | ||
| Unit | Millions | Millions |
![]() | ||
![]() | ||
Total Assets |
4,632,985 |
4,514,890 |
![]() | ||
Current Assets |
3,393,778 |
3,347,912 |
![]() | ||
Total Liabilities |
1,279,828 |
1,277,853 |
![]() | ||
Shareholders Equity |
3,353,156 |
3,266,297 |
![]() | ||
Current Liabilities |
1,097,134 |
1,046,254 |
![]() | ||
| * All the accounts are in IDR. | ||
![]() | ||
Total Operating Revenue |
6,683,638 |
4,865,158 |
![]() | ||
Operational Profit (Loss) |
744,031 |
625,187 |
![]() | ||
Net Profit (Loss) |
627,950 |
549,313 |
![]() | ||
| * All the accounts are in IDR. | ||
| Profitability Ratios | ||
![]() | ||
Return on Assets (ROA) |
13.55% |
12.17% |
![]() | ||
Annualised Return on Assets (ROA) |
13.55% |
16.23% |
![]() | ||
Return on Equity (ROE) |
18.73% |
16.97% |
![]() | ||
Annualised Return on Equity (ROE) |
18.73% |
22.63% |
![]() | ||
Return on Sales (ROS) |
9.47% |
11.35% |
![]() | ||
Return on Capital |
18.72% |
16.96% |
![]() | ||
Gross Profit Margin |
37.53% |
38.69% |
![]() | ||
Operating Profit Margin |
11.55% |
13.5% |
| Efficiency Ratios | ||
![]() | ||
Accounts Receivable Turnover |
8.89x |
7.27x |
![]() | ||
Inventory Turnover |
5.42x |
3.72x |
![]() | ||
Current asset turnover |
1.95x |
1.45x |
![]() | ||
Fixed-asset turnover |
5.35x |
4.15x |
![]() | ||
Asset Turnover |
1.43x |
1.07x |
| Valuation figures and ratios | ||
![]() | ||
Earning Before Interests and Taxes (EBIT) |
742,206 |
623,464 |
![]() | ||
EBITDA |
819,001 |
678,946 |
![]() | ||
Enterprise value |
15,204,887 |
12,315,246 |
![]() | ||
Enterprise Value / EBITDA |
18.57 |
18.14 |
![]() | ||
Bookvalue (BV) |
4,539,146 |
4,360,990 |
![]() | ||
Net Cash |
554,316 |
546,659 |
| Liquidity Ratios | ||
![]() | ||
Current Ratio |
309.33% |
319.99% |
![]() | ||
Quick ratio |
239.64% |
243.72% |
![]() | ||
Doom's day ratio |
150.52% |
152.25% |
| Leverage Ratios | ||
![]() | ||
Leverage ratio |
138.17% |
139.48% |
![]() | ||
Interest Coverage Ratio |
10,717.02% |
11,275.84% |
![]() | ||
Debt to equity |
38.17% |
39.48% |
![]() | ||
Debt to total assets |
27.62% |
28.3% |
![]() | ||
Long Term Debt to Capital |
44.81% |
50.72% |
![]() | ||
Debt / Enterprise Value |
0.62% |
1.25% |
| Market ratios | ||
![]() | ||
Market Capitalization/EBITDA |
20.47 |
20.22 |
![]() | ||
Price/Book Ratio |
3.69 |
3.15 |
![]() | ||
Market Cap / Net cash |
30.24 |
25.11 |
| Trend Ratios | ||
![]() | ||
Revenue Trend |
114.71% |
114.41% |
![]() | ||
Net Income Trend |
110.94% |
109.57% |
![]() | ||
Operating Income Trend |
111.98% |
108.36% |
![]() | ||